MJNA - Medical Marijuana, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.0259
+0.0009 (+3.60%)
At close: 3:59PM EST
Stock chart is not supported by your current browser
Previous Close0.0250
Open0.0250
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0250 - 0.0265
52 Week Range0.0200 - 0.1100
Volume5,373,203
Avg. Volume5,883,928
Market Cap225.496M
Beta (3Y Monthly)-0.78
PE Ratio (TTM)N/A
EPS (TTM)-0.0140
Earnings DateNov 22, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • PR Newswire

    Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Applauds ANVISA's New Regulations of Medical Cannabis Products in Brazil

    Medical Marijuana, Inc. ("the Company") (OTC: MJNA), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that subsidiary HempMeds® Brasil applauds ANVISA (the National Agency for Health Supervision) for unanimously approving the regulation of medical marijuana to be sold at pharmacies and drugstores nationwide. Brazil's new regulations will be published soon on the Federal Official Gazette and entered into law 90 days after that.

  • PR Newswire

    Medical Marijuana, Inc. Subsidiary Kannaway® Receives Two 2019 Best in Biz Awards

    Medical Marijuana, Inc. ("the Company") (OTC: MJNA), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary Kannaway® received a Bronze Best in Biz Award for Most Innovative Product of the Year – Consumer for its high-quality hemp-derived cannabidiol (CBD) products. Also, Kannaway® CEO Blake Schroeder received a Bronze Award for Executive of the Year – Small Companies.

  • Benzinga

    The US Cities Most Interested In Cannabis

    While cannabis has gone from a criminalized drug to a multibillion-dollar boom in recent years, very little data exists on how interest and consumer demand differ around the country, according to Michael Coleman, the vice president of sales and marketing at Medical Marijuana Inc (OTC: MJNA), told Benzinga. "We believe this study can be useful for cannabis executives and entrepreneurs who are looking to make strategic decisions about which markets to enter," he said of the company's most recent report on geographical interest on cannabis across the U.S. The following are highlights from Medical Marijuana Inc.'s report on interest in marijuana in cities nationwide.

  • PR Newswire

    Medical Marijuana, Inc. Reports $17.7 Million in Revenue in Q3 2019 Financial Results

    SAN DIEGO , Nov. 22, 2019 /PRNewswire/ -- Medical Marijuana, Inc. ("the Company") (OTC: MJNA), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever ...

  • PR Newswire

    Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Vice President Invited to Speak on Key Panel at 2019 Marijuana Business Conference

    Caroline Heinz will speak on Dec. 12 at 2:00 p.m. on a panel entitled "Beyond Borders: Looking at Latin America as the New Frontier" discussing business opportunities allowed by regulations throughout Latin America, the current status of key revenue markets, challenges in each Latin American region and how they are being addressed, and Latin American cannabis investment opportunities. "Just like the U.S., Latin America is currently experiencing monumental shifts in acceptance and new legislation," Heinz said.

  • PR Newswire

    Medical Marijuana, Inc. Subsidiary Kannaway® Promotes Alex Grapov to Chief Sales Officer

    SAN DIEGO, Nov. 12, 2019 /PRNewswire/ -- Medical Marijuana, Inc. ("the Company") (MJNA), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary Kannaway® has promoted its International Vice President, Alex Grapov, to Chief Sales Officer of the Company. "Alex has been instrumental to our international sales and operational growth for the past two years and we believe that this new role is the most natural and well-deserved next step for him to take with our Company," said Kannaway® CEO Blake Schroeder.

  • PR Newswire

    Medical Marijuana, Inc. Subsidiary Kannaway® Receives Two 2019 BIG Awards for Business

    SAN DIEGO, Nov. 6, 2019 /PRNewswire/ -- Medical Marijuana, Inc. ("the Company") (MJNA), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary Kannaway® was named Small Business Company of the Year in the Life Sciences, Health, Wellness, and Nutrition category by the Business Intelligence Group's 2019 BIG Awards for Business. Also, Kannaway®'s CEO Blake Schroeder was named Small Business Executive of the Year in the Life Sciences, Health, Wellness, and Nutrition category.

  • PR Newswire

    Medical Marijuana, Inc. and Subsidiaries' 2019 Sales Bookings Surpass Total 2018 Sales Bookings

    SAN DIEGO , Nov. 5, 2019 /PRNewswire/ -- Medical Marijuana, Inc.  ("the Company") (OTC: MJNA), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever ...

  • Medical Marijuana, Inc. Hires Tyler Whatcott as Chief Technology Officer
    PR Newswire

    Medical Marijuana, Inc. Hires Tyler Whatcott as Chief Technology Officer

    SAN DIEGO, Oct. 31, 2019 /PRNewswire/ -- Medical Marijuana, Inc. ("the Company") (MJNA), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that it has hired Tyler Whatcott as the Company's Chief Technology Officer. Mr. Whatcott will be responsible for developing and managing the company's information technology and web platforms as it develops its current business and expands around the world. "Tyler shows great promise in leading the technological operations of our Company as he has already proven his capabilities in leading several successful IT departments at well-established and recognized companies," said Medical Marijuana, Inc. CEO Dr. Stuart Titus.

  • PR Newswire

    Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Speaks at HempToday™'s Latin American and Caribbean Hemp Summit

    SAN DIEGO, Oct. 29, 2019 /PRNewswire/ -- Medical Marijuana, Inc. ("the Company") (MJNA), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that Raul Elizalde, the President of its subsidiary HempMeds® Mexico and Latin American operations, will be a keynote speaker at HempToday™'s Latin American & Caribbean Hemp Summit on Nov. 8-9 in Montevideo, Uruguay. "I am very excited to speak at this event and help people understand the current and potential upcoming legislation on cannabis in Mexico," Elizalde said. According to Grandview Research analysts, Mexico's medical cannabis market size was valued at $47.3 million in 2018.

  • PR Newswire

    Medical Marijuana, Inc. Subsidiary Kannaway® Joins U.S. Hemp Roundtable Board of Directors

    SAN DIEGO, Oct. 22, 2019 /PRNewswire/ -- Medical Marijuana, Inc. ("the Company") (MJNA), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary Kannaway® has been selected as a member of the Board of Directors for the U.S. Hemp Roundtable. The U.S. Hemp Roundtable, formed in 2017, is a coalition of more than 50 leading hemp companies representing every link of the industry's supply chain from seed to sale. "Since forming our company, Kannaway, in association with its parent company Medical Marijuana, Inc. and its other subsidiaries, have participated in many domestic and international efforts to advocate for expanded access to hemp by hosting educational events and speaking with prominent regulatory bodies, including but not limited to the U.S. Food and Drug Administration (FDA), Mexico's Federal Commission for the Protection Against Sanitary Risk (COFEPRIS) and Brazil's National Sanitary Surveillance Agency (ANVISA)," said Kannaway® CEO Blake Schroeder.

  • PR Newswire

    Medical Marijuana, Inc. Subsidiary Kannaway® Announces Hemp for Humanity Educational Event Tour Throughout Japan

    SAN DIEGO , Oct. 17, 2019 /PRNewswire/ --  Medical Marijuana, Inc .  ("the Company") (OTC: MJNA), the first-ever publicly traded cannabis company in the United States that launched the world's ...

  • PR Newswire

    Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Vice President Hosts Panel at Lide Futuro Debate in São Paulo

    SAN DIEGO, Oct. 15, 2019 /PRNewswire/ -- Medical Marijuana, Inc. ("the Company") (MJNA), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, today announced that subsidiary HempMeds® Brasil Vice President Caroline Heinz will be hosting a featured panel at the Lide Futuro Debate entitled, "Cannabusiness: National Potential and Business Segments," on Oct. 18 at the Museum of Image and Sound (MIS) in São Paulo, Brazil. According to a survey by New Frontier Data, Brazil's cannabis market could be worth around $4.4 billion by 2022, equivalent to 6.3 percent of the total revenue of the Brazilian pharmaceutical industry. If projections are correct, Brazil could become a more prominent leader in the Latin American cannabis market, surpassing the cannabis sales revenue of both Mexico and Chile.

  • PR Newswire

    Medical Marijuana, Inc. Subsidiary Kannaway® Announces Launch of New Website and Back Office for Japan Division

    SAN DIEGO, Oct. 10, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA) ("the Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, today announced that its subsidiary Kannaway® has launched a new website and back office available in Japanese catered to servicing the expansion into Japan and Asia. Kannaway®'s new Japanese language website is designed to fit the specific needs of Japanese consumers and business owners. The site will feature the latest news, announcements and promotional offers from Kannaway® in a streamlined and easy-to-navigate design.

  • Medical Marijuana, Inc. Subsidiary Kannaway® and Company CEO Honored in 11th Annual Golden Bridge Awards
    PR Newswire

    Medical Marijuana, Inc. Subsidiary Kannaway® and Company CEO Honored in 11th Annual Golden Bridge Awards

    SAN DIEGO, Oct. 8, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary Kannaway® has earned two prestigious Golden Bridge Awards® -- including a Silver Award for Company of the Year in the Healthcare Products and Services category and the Company's CEO Blake Schroeder earned a Gold Award for International Executive of the Year in the Healthcare Products and Services category.

  • PR Newswire

    Medical Marijuana, Inc. Subsidiary Kannaway® Announces European Road to Area Tour

    SAN DIEGO , Oct. 3, 2019 /PRNewswire/ -- Medical Marijuana, Inc .  ("the Company") (OTC: MJNA), the first-ever publicly traded cannabis company in the United States that launched the world's ...

  • PR Newswire

    Medical Marijuana, Inc. CEO to Speak at Hemp for the Future Event in Reykjavík, Iceland

    SAN DIEGO, Oct. 1, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that the Company's Chief Executive Officer Dr. Stuart Titus will be presenting at the Hemp for the Future educational event in Reykjavík, Iceland, on Oct. 1-2. Medical doctors, scientists, hemp farmers, and patients will share their knowledge on the current industry landscape and future of hemp. "Medical Marijuana, Inc. is one of the hemp industry's leaders on the forefront of developing new international markets, and I am excited to have the opportunity to help pioneer educational efforts in a promising new market such as Iceland," Titus said.

  • Medical Marijuana, Inc. Reaches One-Year Milestone in High-Level CBD Hemp Oil Stability Study
    PR Newswire

    Medical Marijuana, Inc. Reaches One-Year Milestone in High-Level CBD Hemp Oil Stability Study

    SAN DIEGO , Sept. 26, 2019 /PRNewswire/ --  Medical Marijuana, Inc.  (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's ...

  • PR Newswire

    Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Vice President Presents at MJBizDaily Latin American Cannabis Symposium

    SAN DIEGO, Sept. 24, 2019 /PRNewswire/ -- Medical Marijuana, Inc. ("the Company") (MJNA), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, today announced that subsidiary HempMeds® Brasil Vice President Caroline Heinz will be a featured speaker at the MJBizDaily Latin American Cannabis Symposium in Bogotá, Columbia, on Sept. 30 – Oct. 1. Caroline Heinz will speak on Oct. 1 at 9:50 a.m. on a panel entitled "Potential Powerhouse: Where Brazil Stands" discussing the potential for upcoming reform in which domestic cultivation would be regulated and cannabis products could be registered without finished clinical trials for the first time in Brazil. The panel will also discuss how to prepare to cultivate cannabis in Brazil and what significant new business opportunities this reform could create for the entire Latin American cannabis industry.

  • PR Newswire

    Medical Marijuana, Inc. Subsidiary Kannaway® Announces Super Academy Event and Product Launch in Amsterdam

    SAN DIEGO, Sept. 19, 2019 /PRNewswire/ -- Medical Marijuana, Inc. ("the Company") (MJNA), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, today announced that its subsidiary Kannaway® is hosting a Super Academy event in Amsterdam on Sept. 27-29. The event will give Kannaway®'s European Brand Ambassadors the opportunity to network with top Kannaway® Europe leaders, the Company's global executive team and fellow business owners. The Brightfield Group predicts that "impending regulatory changes" will drive Europe's CBD market from $318 million last year to $416 million in 2019, and also projects that market will surge 400% to $1.7 billion by 2025.

  • Market Exclusive

    AXIM to Launch CBD Chewing Gum to Treat Chemotherapy Symptoms

    Medical Marijuana (OTC: MJNA) announced that its major investment company AXIM Biotechnologies (OTCQB: AXIM) is making its cannabinoid-based chewing gum to treat chemotherapy-related symptoms. The chewing gum with dronabinol, a synthetic form of tetrahydrocannabinol (THC), is being manufactured through AXIM's contract manufacturer Eurofins Amatsigroup in Belgium. It will be used in AXIM's upcoming clinical studies on cannabis as a treatment […]The post AXIM to Launch CBD Chewing Gum to Treat Chemotherapy Symptoms appeared first on Market Exclusive.

  • PR Newswire

    Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Signs Agreement with Online Marketplace Dr. Cannabis

    SAN DIEGO, Sept. 17, 2019 /PRNewswire/ -- Medical Marijuana, Inc. ("the Company") (MJNA), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, today announced that its subsidiary HempMeds® Brasil, the first Anvisa-authorized company to import cannabidiol (CBD)-based medicines in the country, has signed a partnership agreement for Dr. Cannabis, an online marketplace that facilitates patient access to medical cannabis, to become the exclusive Brazilian reseller of the Company's CBD products. Since 2014, almost 10,000 authorizations have been granted to individual patients, allowing them to import medical cannabis on a case-by-case basis, each for a period of up to one year.

  • PR Newswire

    Medical Marijuana, Inc. Major Investment Company AXIM® Biotechnologies Begins GMP Manufacturing Of Cannabinoid-Based Gum With Dronabinol For Use In Upcoming Clinical Studies

    SAN DIEGO , Sept. 12, 2019 /PRNewswire/ --  Medical Marijuana, Inc . (OTC: MJNA) ("the Company"), the first-ever publicly traded cannabis company in the United States that launched the world's ...

  • PR Newswire

    HempMeds®, Subsidiary of Medical Marijuana, Inc., Announces Presence at Natural Products Expo East

    SAN DIEGO, Sept. 10, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA) ("the Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary HempMeds® will be attending and exhibiting at Natural Products Expo East in Baltimore, Maryland, on Sept. 11-14. According to a 2019 report by Natural Food Merchandiser magazine, the Natural Products Market produced over $158 million in sales in 2018 and is projected to grow by 49 percent in 2019. At the conference, HempMeds® will exhibit its well-trusted hemp-derived CBD lifestyle brands such as its Real Scientific Hemp Oil™ and Dixie Botanicals® as well as the Company's Personal Care Line of hair and skincare products, Everyday Wellness Line of functional products and brand new pet products.

  • PR Newswire

    Medical Marijuana, Inc. and Subsidiary Dixie Botanicals® Secure National News Coverage in Leading Financial Publication Benzinga

    SAN DIEGO , Sept. 3, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever ...